Cell Source Shareholders’ Equity Growth & History (CLCS)

Cell Source's shareholders’ equity was −$18.5M for fiscal 2024.

View full Cell Source company overview

Cell Source annual shareholders’ equity history

Cell Source annual shareholders’ equity

Fiscal yearPeriod endedShareholders’ equityChangeGrowth
20242024-12-31−$18.5M−$2.9M
20232023-12-31−$15.6M−$3.0M
20222022-12-31−$12.6M−$2.8M
20212021-12-31−$9.8M−$1.9M
20202020-12-31−$7.9M−$2.2M
20192019-12-31−$5.7M−$821,770
20182018-12-31−$4.9M−$362,797
20172017-12-31−$4.6M$1.7M
20162016-12-31−$6.2M−$484,700
20152015-12-31−$5.8M−$2.0M
20142014-12-31−$3.8M−$3.1M
20132013-12-31−$697,334

Cell Source shareholders’ equity trends

Over the last five fiscal years, Cell Source's shareholders’ equity decreased from −$5.7M to −$18.5M, a change of −$12.8M. The latest reported quarter, Q1 2025, shows −$20.1M.

About the metric

What shareholders’ equity means

Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.

Calculation and source

SEC-reported shareholders’ equity

TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cell Source source filings ↗

Community posts

It’s quiet here.

No posts about CLCS yet. Start the conversation.

Write the first post